Summary

Spatial Genomics and Transcriptomics Market Size
The global spatial genomics and transcriptomics market size was valued at $290.18 million in 2024 and is projected to reach $604.15 million by 2030, growing at a CAGR of 13.0% during the forecast period.

Spatial Genomics and Transcriptomics Market Overview
Spatial genomics and transcriptomics are advanced techniques that enable the study of genetic material and gene expression within the spatial context of tissues. Unlike traditional methods that analyze genes and transcripts in bulk, spatial genomics and transcriptomics preserve the spatial information, allowing scientists to see where specific genes are active within a tissue. This is crucial for understanding the complex interactions and functions of different cell types within their native environments. These techniques utilize various technologies, such as in situ hybridization and sequencing, to map the location of DNA and RNA molecules directly within tissue sections. This spatially resolved data provides insights into cellular heterogeneity, tissue architecture, and the molecular mechanisms underlying development, disease, and other biological processes.

Spatial Genomics and Transcriptomics Market Dynamics
• The spatial genomics and transcriptomics market is expected to witness significant growth in the future due to advancements in sequencing technologies, growing demand for personalized medicine, and increasing investments in research and development.
• Additionally, the rising prevalence of chronic diseases and cancer, expansion of bioinformatics and computational biology, and development of innovative and cost-effective technologies are the prominent factors driving the growth of the market.
• However, the high costs of spatial genomics and transcriptomics technologies, limited availability of skilled professionals, and technical challenges and complexity of data interpretation are restraining the market growth.
• On the contrary, the expansion into emerging markets and regions, strategic collaborations and partnerships, and growing application in drug discovery and development are creating opportunities for market growth.

By Product, the Consumables Segment is anticipated to Hold Major Share in the Spatial Genomics and Transcriptomics Market
The consumables segment is expected to dominate the market share during the forecast period owing to its crucial role in enabling high-throughput and precise genomic and transcriptomic analysis. Consumables such as reagents, assay kits, and disposable lab supplies are essential components in conducting experiments and analyses at scale, providing researchers with the necessary tools to process and analyze biological samples effectively. As advancements in genomic and transcriptomic technologies continue to accelerate, there is a growing need for consumables that support these innovative techniques, including single-cell RNA sequencing and spatial profiling assays. The consumables segment not only facilitates the collection and preparation of high-quality data but also ensures reproducibility and reliability in research outcomes. With increasing investments in biomedical research and personalized medicine, the consumables segment of Spatial Genomics and Transcriptomics is poised for substantial growth, driven by the demand for reliable, scalable, and high-quality tools that underpin advancements in understanding disease mechanisms and developing targeted therapies.

By Geography, North America is expected to grow at a highest CAGR during the forecast period
North America is anticipated to experience the highest compound annual growth rate during the forecast period due to the region's leadership in biomedical research and technological innovation and academic centers focused on advancing genomic and transcriptomic technologies. These technologies enable researchers to study gene expression and spatial organization within tissues at unprecedented resolution, offering insights into complex biological processes and disease mechanisms. In particular, advancements in single-cell analysis and spatial profiling techniques have revolutionized the understanding of cellular interactions and heterogeneity in disease states, paving the way for personalized medicine approaches and targeted therapies. Moreover, the region's supportive regulatory environment and substantial investments in healthcare and life sciences research contribute to the rapid adoption and development of spatial genomics and transcriptomics technologies.

Key Target Audience:
• Research Institutions and Academic Laboratories
• Biotechnology and Pharmaceutical Companies
• Government Research Agencies
• Diagnostic and Clinical Research Laboratories
• Genomics and Transcriptomics Technology Providers


List of the Key Players Profiled in the Report Includes:
• NanoString Technologies, Inc.
• 10X Genomics
• Illumina
• Bio-Rad Laboratories
• Bio-Techne Corporation
• Standard BioTools Inc.
• Genomic Vision SA
• Akoya Biosciences, Inc.
• Danaher Corporation
• Natera, Inc.
• PerkinElmer, Inc.
• Seven Bridges Genomics

Recent Developments:
• In June 2024, 10x Genomics, Inc revealed its Xenium In Situ platform played a pivotal role in a study featured in the Journal of Dental Research, providing new insights into cellular mechanisms governing the development of the secondary palate.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Spatial Technique:
• Fluorescence In-Situ Sequencing
• Fluorescence Microscopy
• Fluorescent In-Situ Hybridization (FISH)
• Immunohistochemistry (IHC)
• In-Silico Construction
• In-Situ Capturing
• Microscopy-Based RNA Imaging Techniques
• Sequencing
• Spatial Genomics Analysis
• Spatial Transcriptomics
• Transcriptome In-Vivo Analysis (TIVA)
• Other Techniques

Market by, Product:
• Bioinformatics Tools
• Consumables
• Instruments
• Imaging Tools
• Software
• Storage and Management Databases

Market by, Application:
• Drug Discovery and Development
• Translational Research

Market by, End User:
• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies

Market by, Geography:
The spatial genomics and transcriptomics market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

Scope of the Report:
The report “Global Spatial Genomics and Transcriptomics Market: Industry Analysis, Opportunities and Forecast up to 2030” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2022, 2023 and offers revenue estimations for 2024, and project forecasts spanning from 2025 to 2030. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Spatial Genomics and Transcriptomics Market by, Technique
6.1 Overview
6.2 Fluorescence In-Situ Sequencing
6.3 Fluorescence Microscopy
6.4 Fluorescent In-Situ Hybridization (FISH)
6.5 Immunohistochemistry (IHC)
6.6 In-Silico Construction
6.7 In-Situ Capturing
6.8 Microscopy-Based RNA Imaging Techniques
6.8.1 Branched DNA Probes
6.8.2 Padlock Probes/ Rolling Circle Amplification
6.8.3 Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
6.9 Sequencing
6.9.1 In Situ Sequencing
6.9.2 Microdissection Sequencing
6.9.3 Other Sequencing Techniques
6.10 Spatial Genomics Analysis
6.11 Spatial Transcriptomics
6.12 Transcriptome In-Vivo Analysis (TIVA)
6.13 Other Techniques

7 Global Spatial Genomics and Transcriptomics Market by, Product
7.1 Overview
7.2 Bioinformatics Tools
7.3 Consumables
7.4 Instruments
7.4.1 Mode
7.4.2 Type
7.5 Imaging Tools
7.6 Software
7.7 Storage and Management Databases

8 Global Spatial Genomics and Transcriptomics Market by, Application
8.1 Overview
8.2 Drug Discovery and Development
8.3 Translational Research

9 Global Spatial Genomics and Transcriptomics Market by, End User
9.1 Overview
9.2 Academic & Research Institutes
9.3 Contract Research Organizations
9.4 Pharmaceutical & Biotechnology Companies

10 Global Spatial Genomics and Transcriptomics Market by, Geography
10.1 Overview
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 New Zealand
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Qatar
10.6.4 Iran
10.6.5 South Africa
10.6.6 Rest of Middle East & Africa

11 Key Developments

12 Company Profiling
12.1 NanoString Technologies, Inc.
12.1.1 Business Overview
12.1.2 Product/Service Offering
12.1.3 Financial Overview
12.1.4 SWOT Analysis
12.1.5 Key Activities
12.2 10X Genomics
12.3 Illumina
12.4 Bio-Rad Laboratories
12.5 Bio-Techne Corporation
12.6 Standard BioTools Inc.
12.7 Genomic Vision SA
12.8 Akoya Biosciences, Inc.
12.9 Danaher Corporation
12.10 Natera, Inc.
12.11 PerkinElmer, Inc.
12.12 Seven Bridges Genomics